Remdesivir details as on 26th May (Wednesday), 2021:
|Quantity manufactured in India by Dr. Reddy's||34464 vials|
|Supplied to Maharashtra||0 vials|
Dr.Reddy’s in India
Dr. Reddy’s commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
Portfolio spanning wide range of therapy and disease areas
Over the years, the company has significantly grown its portfolio of products across mass and specialty therapies. Today, our portfolio has over 200 products covering the whole spectrum of disease areas spanning gastroenterology, oncology, pain management, cardiovascular, dermatology, urology, nephrology, rheumatology and diabetes. Seven of our brands are listed in “Top-300 of the Indian Pharma Market” and many others hold leadership positions in their respective categories.
Ensuring that medicines are available when needed
Dr. Reddy’s has built a robust field force driven by the zeal to make a difference in the lives of patients. The 5000-member strong team network connects with more than three lakh doctors on a regular basis to ensure that quality medicines we make are available for patients across the length and breadth of the country. Their efforts are backed by our unique inventory management system, VIVA (Viable Vision), to ensure that the medicines are available for patients when they need it.
Going beyond the pill to address patient needs
As a company we have progressively transitioned from being a maker of molecules to a provider of medicines. Along the way we developed a deeper empathy for the needs of patients and their caregivers. This has impelled Dr. Reddy’s as an organization to go beyond medicines and leverage our capabilities to meet some of these unmet patient needs. Our Purple Health initiative in India aims at taking patient care beyond the pill focusing our efforts in four areas:
- Disease awareness and convenient diagnosis
- Access to medicines
- Better therapy experience
- Adherence to therapy